CG Oncology, Inc.
CGON
$25.42
-$1.50-5.56%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/26/2025
-
MarketBeat
8/23/2025
-
Simply Wall St
8/23/2025
-
MarketBeat
8/21/2025
-
MarketBeat
8/19/2025
-
Insider Monkey
8/19/2025
-
TipRanks Financial Blog
8/19/2025
-
The Fly
8/18/2025
-
The Fly
8/18/2025
-
Insider Monkey
8/17/2025
-
Ticker Report
8/16/2025
-
MarketBeat
8/15/2025
-
MarketBeat
8/13/2025
-
GuruFocus
8/13/2025
-
TipRanks Financial Blog
8/13/2025
-
Simply Wall St
8/12/2025
-
ETF Channel
8/12/2025
-
MarketBeat
8/11/2025
-
MarketBeat
8/10/2025
-
TipRanks Financial Blog
8/10/2025
-
The Fly
8/10/2025
-
TipRanks Financial Blog
8/10/2025
-
MarketBeat
8/9/2025
-
Simply Wall St
8/9/2025
-
GuruFocus
8/9/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, August 8, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
949 409 3700
Address
400 Spectrum Center Drive
Irvine, CA 92618
Irvine, CA 92618
Country
Year Founded
Business Description
Sector
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops...
more